BSE Live
Nov 07, 16:01Prev. Close
1584.45
Open Price
1599.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 07, 15:41Prev. Close
1585.40
Open Price
1591.30
Bid Price (Qty.)
1594.20 (98)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Eris Lifesciences (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 102.61 | 88.92 | 90.50 | 66.26 | |
| Net CashFlow From Operating Activities | 92.37 | 89.69 | 40.41 | 32.24 | |
| Net Cash Used In Investing Activities | -94.36 | -84.64 | -40.75 | -21.72 | |
| Net Cash Used From Financing Activities | 0.99 | -0.43 | -1.12 | -7.22 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -1.00 | 4.63 | -1.46 | 3.30 | |
| Cash And Cash Equivalents Begin of Year | 5.90 | 1.28 | 2.73 | 5.56 | |
| Cash And Cash Equivalents End Of Year | 4.91 | 5.90 | 1.28 | 8.86 |
25.08.2025
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
08.08.2025
06.08.2025
Buy Eris Lifesciences; target of Rs 1975: Prabhudas Lilladher
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
05.08.2025
Eris Life Standalone June 2025 Net Sales at Rs 578.64 crore, up 26.7% Y-o-Y
20.05.2025
Eris Life Consolidated March 2025 Net Sales at Rs 705.30 crore, up 28.02% Y-o-Y
20.05.2025
Eris Life Standalone March 2025 Net Sales at Rs 404.77 crore, up 18.6% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher